$CYTK

21 stories mentioning CYTKUpdated 1d ago

Every FINWIRES story that references CYTK, newest first.

Cytokinetics Insider Sold Shares Worth $491,783, According to a Recent SEC Filing

Andrew Callos, Executive Vice President, Chief Commercial Officer, on April 15, 2026, sold 7,449 shares in Cytokinetics (CYTK) for $491,783. Following the Form 4 filing with the SEC, Callos has control over a total of 58,555 common shares of the company, with 58,555 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1061983/000106198326000036/xslF345X05/form4.xml

$CYTK

Showing 21-21 of 21

Track with the FINWIRES app suite

FolioX

Track CYTK in your portfolio

WheelAI

Analyze CYTK options with the wheel strategy

StockInsider

See market sentiment on CYTK